Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EMA Official Clarifies Benefits And Limitations Of Innovation Pathways

Jun 02 2025

• By Eliza Slawther

EMA head of orphan medicines Kristina Larsson presenting virtually at the RAPS Euro Convergence 2025 — EMA head of orphan medicines Kristina Larsson presenting virtually at the RAPS Euro Convergence 2025 (Pink Sheet)

Related Content

New EMA Innovation Group To Provide Point Of Entry For Developers & Contribute To Regulatory Assessments

Nov 23 2022

Winners And Losers: A Deep-Dive Into The EMA’s PRIME Scheme

Aug 17 2020

‘Come Early, Come Often,’ EMA Chief Tells Industry

Apr 29 2025

More from RAPS

More from Conferences

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window